Cargando…
Tissue Damage in the Canine Normal Esophagus by Photoactivation with Talaporfin Sodium (Laserphyrin): A Preclinical Study
BACKGROUND: Treatment failure at the primary site after chemoradiotherapy is a major problem in achieving a complete response. Photodynamic therapy (PDT) with porfimer sodium (Photofrin®) has some problems such as the requirement for shielding from light for several weeks and a high incidence of ski...
Autores principales: | Horimatsu, Takahiro, Muto, Manabu, Yoda, Yusuke, Yano, Tomonori, Ezoe, Yasumasa, Miyamoto, Shinichi, Chiba, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374776/ https://www.ncbi.nlm.nih.gov/pubmed/22719875 http://dx.doi.org/10.1371/journal.pone.0038308 |
Ejemplares similares
-
Preclinical Validation of Talaporfin Sodium-Mediated Photodynamic Therapy for Esophageal Squamous Cell Carcinoma
por: Ohashi, Shinya, et al.
Publicado: (2014) -
Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer
por: Yano, Tomonori, et al.
Publicado: (2012) -
Clinical Practice of Photodynamic Therapy Using Talaporfin Sodium for Esophageal Cancer
por: Yano, Tomonori, et al.
Publicado: (2021) -
Repeated talaporfin sodium photodynamic therapy for esophageal cancer: safety and efficacy
por: Tamaoki, Masashi, et al.
Publicado: (2021) -
A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer
por: Yano, Tomonori, et al.
Publicado: (2016)